IPP Bureau
Krsnaa Diagnostics appoints Dr Ravinder Sethi as Chief Operating Officer
By IPP Bureau - March 14, 2022
He was earlier associated with leading industry players like Hindustan Unilever, TATA Communications, Dr. Lal Path Labs, Oncquest and Metropolis Healthcare
USFDA clears Niramai's breast thermography device
By IPP Bureau - March 14, 2022
The SMILE-100 System is a breast thermography device that helps healthcare personnel review, measure and analyze thermally significant indications in the breast region
Applications for PLI in bulk drugs extended till March 31st 2022
By IPP Bureau - March 14, 2022
A total of 49 projects have been approved so far for 33 critical APIs with a committed investment of Rs 3,685 crore
Corbevax to be administered to children between 12-14 years
By IPP Bureau - March 14, 2022
Govt announces vaccination programme for kids and those above 60 years of age
Dr Federica Fiorini is the winner of the 2022 Darlene Solomon award
By IPP Bureau - March 14, 2022
The award recognizes and supports promising women scientists
Moderna dosed the first participant for an experimental HIV trimer mRNA vaccine
By IPP Bureau - March 14, 2022
The open-label, multicenter, randomized Phase 1 trial is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines
Illumina welcomes Carissa Rollins as Chief Information Officer
By IPP Bureau - March 14, 2022
Most recently, Rollins was the Chief Information Officer at UnitedHealthcare
Adlarity receives USFDA approval for treatment of Alzheimer
By IPP Bureau - March 14, 2022
First and only once-weekly patch for convenient, well-tolerated delivery of most used drug for the treatment of Alzheimer's-related dementia
S.M.A.R.T. Radianz Vascular Stent System approved for transradial use in the U.S.
By IPP Bureau - March 13, 2022
It signals Cordis' renewed investment in innovation
Japan tops CPhI ‘API Quality’ ranking for second year
By IPP Bureau - March 13, 2022
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
New data show Lynparza demonstrated overall survival benefit in early breast cancer
By IPP Bureau - March 12, 2022
Lynparza is approved in the US, EU, Japan and several other countries for the treatment of patients with gBRCAm, HER2-negative, metastatic breast cancer previously treated with chemotherapy based on results from the OlympiAD Phase III trial
Wipro and Pandorum partner to accelerate regenerative medicine with AI
By IPP Bureau - March 12, 2022
Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes
Govt earmarks Rs 500 crore for pharma clusters and MSMEs
By IPP Bureau - March 12, 2022
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme
Terran Biosciences acquires Concert’s CNS therapeutics portfolio
By IPP Bureau - March 12, 2022
These new chemical entities are covered by composition of matter patent applications. Financial terms of the deal were not disclosed
China approves BeiGene’s tislelizumab
By IPP Bureau - March 12, 2022
Tislelizumab is now approved for seven indications in China
